You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


Immunotherapy x

Metastatic triple negative breast cancer is one of the most aggressive and fatal forms of breast cancer. Currently, there is no cure.

Immunotherapy Extends Lives for Patients with Advanced Triple Negative Breast Cancer

Triple-negative breast cancer is an aggressive disease with a high likelihood of spreading to other tissues, a process called metastasis. TNBC is primarily treated with chemotherapy.

One of the most exciting new developments in cancer medicine is immunotherapy— treatments that can harness the power of the immune system to fight cancer. One exciting new class of drugs are called checkpoint inhibitors.

There has been a renewed excitement about cancer immunotherapy (IT), but while new IT approaches have been successful in some cancers including lung and melanoma, there has been much less success in patients with breast cancer.

Dr. Leisha Emens is at the Johns Hopkins Kimmel Cancer Center and the Bloomberg-Kimmel Institute for Cancer Immunotherapy.

After studying immunology as a graduate student, Dr. Robert Vonderheide was so amazed by its complexity and potential in medicine that he decided to go to medical school. As a medical oncologist, Dr.